| |
| |
|
| Insider
Information: |
Middleton Fred A |
| Relationship: |
|
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
593,164 |
|
|
Indirect Shares
|
7,544,680 |
|
|
| Direct
Value |
$3,059,061 |
|
|
|
Indirect Value
|
$6,091,574 |
|
|
| Total
Shares |
8,137,844 |
|
|
| Total
Value |
$9,150,635 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 2.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stereotaxis Inc |
STXS |
Director |
2018-03-02 |
303,528 |
2018-03-02 |
1,325,167 |
Premium* |
|
|
Mmrglobal Inc |
MMRF |
Director |
2008-12-09 |
0 |
2006-03-07 |
2,773,091 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-24 |
70,399 |
2013-06-24 |
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2023-11-17 |
207,523 |
2023-11-17 |
3,407,954 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
|
2024-01-23 |
11,714 |
2024-01-23 |
38,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CMRX |
Chimerix Inc |
Director |
– • – |
2019-11-11 |
4 |
B |
$1.66 |
$33,190 |
D/D |
20,000 |
117,523 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2017-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
119,682 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2011-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,468,104 |
128,479 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2004-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
37,718 |
140,947 |
|
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2005-05-17 |
4 |
B |
$7.79 |
$7,790 |
D/D |
1,000 |
141,947 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-18 |
4 |
AS |
$29.48 |
$872,608 |
I/I |
(29,600) |
145,298 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2006-09-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,703) |
145,506 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2019-11-13 |
4 |
B |
$1.82 |
$54,567 |
D/D |
30,000 |
147,523 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2005-06-08 |
4 |
B |
$7.10 |
$41,910 |
D/D |
5,828 |
147,775 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
149,682 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2005-11-18 |
4 |
B |
$6.32 |
$24,016 |
D/D |
3,800 |
151,575 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2006-09-27 |
4 |
OE |
$6.53 |
$1,974,691 |
I/I |
278,010 |
153,209 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2015-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
170,999 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2008-03-11 |
4 |
B |
$3.40 |
$82,992 |
D/D |
23,800 |
173,386 |
3.92 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2008-03-12 |
4 |
B |
$3.77 |
$4,533 |
D/D |
1,200 |
174,586 |
3.84 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(557,845) |
174,898 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2011-02-08 |
4 |
B |
$7.00 |
$1,874,999 |
I/I |
267,857 |
184,131 |
2.1 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2011-02-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
185,960 |
|
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2016-01-15 |
4 |
B |
$2.80 |
$56,000 |
D/D |
20,000 |
190,999 |
2.39 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
194,049 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-05-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
197,349 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2020-03-12 |
4 |
B |
$1.40 |
$69,900 |
D/D |
50,000 |
197,523 |
2.39 |
% |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2008-03-14 |
4 |
B |
$3.63 |
$85,299 |
D/D |
23,200 |
197,786 |
3.92 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2021-06-25 |
4 |
B |
$7.78 |
$23,729 |
D/D |
3,050 |
200,573 |
2.39 |
% |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2016-01-19 |
4 |
B |
$2.79 |
$27,900 |
D/D |
10,000 |
200,999 |
2.39 |
- |
|
133 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
